Recombinant Human Anti-PDGFR1 x Human Anti-VEGF Bispecific Antibody (scFv-CH1/CL) (BSCC-H349)

Recombinant Anti-PDGFR1 x Anti-VEGF Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-PDGFR1 antibody variable domain is fused to CH1 and the other scFv from an anti-VEGF antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can bind two antigens simultaneously. It is designed for the research of Neovascular ocular disorders; Cancers therapy.

Datasheet INQUIRY

Specifications

Targets

PDGFR1 & VEGF

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Neovascular ocular disorders; Cancers

Targets

Target 1

PDGFR1

Gene ID

5159

UniProt ID

P09619

Alternative Names

IMF1; KOGS; IBGC4; JTK12; PDGFR; PENTT; CD140B; PDGFR1; PDGFR-1; PDGFRβ; platelet-derived growth factor receptor beta; PDGFRB

Target 2

VEGF

Gene ID

7422

UniProt ID

P15692

Alternative Names

VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-PDGFR1 x Human Anti-VEGF Bispecific Antibody (scFv-CH1/CL) (BSCC-H349). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-PDGFR1 x Human Anti-VEGF Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-H349)

Specifications

Targets

Customer Reviews and Q&As